ANTI-INFLAMMATORY ACTIVITY OF PLANTAGO MAJOR LEAF EXTRACTS IN VITRO ON EPITHELIAL CELLS OF THE ORAL CAVITY

The large plantain has been widely used since ancient times to treat many diseases, including constipation, cough and ulcers. The purpose of this study is to review the traditional use, botanical characteristics, pharmacological activity, phytochemical effects and toxicity of Plantago major. Some o f its traditional properties, including wound healing, antipyretic, antitussive, anti-infective, anti-hemorrhagic, anti-inflammatory, diuretic, laxative, astringent and hemostatic, have been confirmed by recent studies. Phytochemical studies have shown that Plantago major contains volatile compounds, triterpenoids, phenolic acids and flavonoids. Current pharmacological studies have proven some of the traditional uses of Plantago major. However, additional studies of this plant are needed, since it can be used for the production of various natural preparations.
The healing properties of the great plantain have been recognized all over the world for hundreds of years. This plant contains a number of effective chemical components, such as flavonoids, alkaloids, terpenoids, phenolic acid derivatives, iridoid glycosides, fatty acids, polysaccharides and vitamins, which contribute to its specific therapeutic effect. Accordingly, studies have shown that the large plantain is effective as a wound healing agent, as well as as an anti-cancer, antidiabetic, antidiarrheal, anti-inflammatory, antinociceptive, antibacterial and antiviral agent. It also fights fatigue and cancer, is an antioxidant and neutralizes free radicals.

1. Powis G. Dose-dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in man. Drug metabolism reviews 1983: 14(6): 1145-1163.

2. Rajkumar V., Gunjan G., Ashok Kumar R., Lazar M. Evaluation of cytotoxic potential of Acorus calamus rhizome. Ethnobotanical leaflets 2009: 7: Article 2.

3. Gali-Muhtasib H., Bakkar N. Modulating cell cycle: current applications and prospects for future drug development. Current cancer drug targets 2002: 2(4): 309-336.

4. Wang H., Zhao C., Huang Y., Wang F., Li Y. Chemical constituents and bioactivities of plantaginis herba. Hong Kong medicinal journal 2015; 22: 29-35.

5. Najafian Y., Hamedi S.S., Farshchi M.K., Feyzabadi Z. Plantago major in traditional Persian medicine and modern phytotherapy: a narrative review. Electronic physician 2018; 10(2): 6390-6399.

6. Radu N., Ghita I., Coman O., Rau I. Therapeutic effect of flavonoids derived from Plantago species. Molecular crystals and liquid crystals 2010: 523(1): 273-281.

7. Radu N., Ghita I., Rau I. Therapeutic effect of polysaccharides from Plantago species. Molecular crystals liquid crystals 2010: 523(1): 236-246.

8. Dalar A., Turker M., Konczak I. Antioxidant capacity and phenolic constituents of Malva neglecta Wallr. and Plantago lanceolata L. from Eastern Anatolia Region of Turkey. Journal of herbal medicine 2012; 2: 42-51.

9. Afifi M., Salama O., Hassan M., Naeim Z., Mohammed K. Phenolic constituents of Plantago albicans L. Journal of pharmaceutical sciences 2000: 16(2): 204-212.

10. Samuelsen A.B. The traditional uses, chemical constituents and biological activities of Plantago major L. A review. Journal of ethnopharmacology. - 2000: 71(1-2): 1-21.

11. Ronsted N., Gobel E., Franzyk H., Jensen S.R., Olsen C.E. Chemotaxonomy of Plantago. Iridoid glucosides and caffeoyl phenylethanoid glycosides. Phytochemistry 2000; 55(4): 337-348.

12. Taskova R., Evstatieva L., Handjieva N., Popov S. Iridoid patterns of genus Plantago L. and their systematic significance. Zeitschrift fur naturforschung C. 2002: 57(1-2): 42-50.